Methyl (1R,5S)-3-(2,2-dimethyl-1,3-benzodioxol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate
C19H23NO4 — CID 134918421
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl (1R,5S)-3-(2,2-dimethyl-1,3-benzodioxol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate
Methyl (1R,5S)-3-(2,2-dimethyl-1,3-benzodioxol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate (PubChem CID 134918421) has the molecular formula C19H23NO4 and a molecular weight of 329.40 g/mol. Its IUPAC name is methyl (1R,5S)-3-(2,2-dimethyl-1,3-benzodioxol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate.
Molecular Properties
| Compound Name | Methyl (1R,5S)-3-(2,2-dimethyl-1,3-benzodioxol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate |
|---|---|
| PubChem CID | 134918421 |
| Molecular Formula | C19H23NO4 |
| Molecular Weight | 329.40 g/mol |
| Exact Mass | 329.16 |
| IUPAC Name | methyl (1R,5S)-3-(2,2-dimethyl-1,3-benzodioxol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate |
| SMILES | COC(=O)C1=C(c2ccc3c(c2)OC(C)(C)O3)C[C@@H]2CC[C@H]1N2C |
| InChI | InChI=1S/C19H23NO4/c1-19(2)23-15-8-5-11(9-16(15)24-19)13-10-12-6-7-14(20(12)3)17(13)18(21)22-4/h5,8-9,12,14H,6-7,10H2,1-4H3/t12-,14+/m0/s1 |
| InChIKey | URLMJPDSYJJPIK-GXTWGEPZSA-N |
| XLogP | 2.99 |
| TPSA | 48.00 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 329.40 |
| LogP ≤ 5 | 2.99 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134918421 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.